Navigation Links
Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order
Date:11/20/2007

the Company's new products; decisions by customers to place orders for the Company's products; the risks associated with reliance on a few key customers; the Company's ability to attract and retain personnel with the necessary scientific and technical skills; the timing and completion of significant orders; the timing and amount of the Company's research and development expenditures; the timing and level of market acceptance of customers' products for which the Company supplies components; performance of the Company's vendors; the ability of the Company to control costs associated with performance under fixed price contracts; the continued availability to the Company of essential supplies, materials and services; and the other risk factors and cautionary statements listed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission, including but not limited to, the Company's Annual Report on Form 10-KSB for the year ended June 30, 2007.


'/>"/>
SOURCE Precision Optics Corporation, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years
2. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
3. New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput
4. AZoOptics.com - The A to Z of Optics Launched By AZoNetwork
5. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
6. Brooke Franchise Corporation Announces Selected July Results
7. MedThink Communications Retained by NanoBio Corporation
8. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
9. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
10. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
11. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ench and Spanish . , Researchers at the U...alled ,gene E, which leads to the death of tumour... and prevents their growth. The importance of this...ce the potent drugs that are currently used, so th... , This research was conducted by Ana Rosa Rama...
(Date:11/24/2009)...rman . , Internationally viewed, medical car... as far as survival is concerned. However, other a...rm consequences of the disease are still insuffici...ion of the Institute for Quality and Efficiency in... on 16 October 2009. , Establish mandatory qual...
(Date:11/24/2009)...lastic surgery experts from the American Society o...s the recently proposed cosmetic surgery tax. , ...s) November 24, 2009 -- Leading plastic surgery ex...s (ASPS), are available to discuss the recently pr...e nation’s leading plastic surgery experts a...
(Date:11/24/2009)...th undesirable blood levels, analysis shows , ...mal cholesterol levels can significantly increase ..., U.S. researchers analyzed data on 6,860 parti...titute,s Framingham Heart Study. None of the parti...e at the start of the study. After about 26 years ...
(Date:11/24/2009)...evice regulatory consulting firm Emergo Group rece..., distributors and industry service providers abou...ion plans and their outlook for 2010. , ...2009 -- Global medical device regulatory consulti...al device and IVD manufacturers, distributors and ...
Breaking Medicine News(10 mins):Health News:Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage 2Health News:In Germany, children with cancer have a high probability of survival 2Health News:In Germany, children with cancer have a high probability of survival 3Health News:Leading Plastic Surgery Experts Available to Discuss Proposed ,Cosmetic Surgery Tax 2Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:Medical Device Industry Positive About 2010 – Survey 2
...n proposed by researchers at Medical College of Wi... assess the improvement in survival rate in cardia... The study would be funded by the National Heart...ardiac arrest and severe traumatic injury, and wou...
...ropean breast cancer conference (EBCC-5) had docto...st cancer research and improve patient care//. Bre...n women. But as of now the survival rates are impr...ation for Research and Treatment of Cancer (EORTC)...
...to the study conducted by Theodore Blaine, M.D., a...bia University Medical Center and an attending// s...aluronate, a drug that is FDA-approved for osteoar...other Cox-2 inhibitors. After that people went for...
...ts suffering from chronic shoulder pain were left ...dvil or to go for a surgery//, after the safety co...s were raised. But a research done by Columbia Uni... the shoulder pain. The study was presented ...
...g maker Sanofi-Aventis SA announced on Thursday th...d its cancer drug Taxotere to treat patients with ...e can be used in combination with chemotherapy dru...es of breast cancer and lung cancer. Certain types...
...rs believe that enforced bicycle helmet laws impro...this view aside.// Several studies suggest t... head injuries than non-wearers. But Dorothy Robin...e public health. She reviewed data from coun...
Other Medicine News:Health News:An Effective Drug Identified for Shoulder Pain 2Health News:New Drug For Treating Chronic Shoulder Pain 2Health News:New Drug For Treating Chronic Shoulder Pain 3Health News:Can Enforcing Bicycle Helmet Laws Avoid Head Injuries? 2
(Date:11/24/2009)...RNewswire/--MAQUETCardiovascularLLC,aleadingprovid...thassignedaguaranteedtwo-yearcontractwithNovation,...s,tobethesolesourceproviderofsurgicaldevicesforbea...greement,whichrunsthroughOctober31,2012,MAQUETCard...devicesanddisposablesuppliestothemembersofVHAInc.a...
(Date:11/24/2009)...ewswire-FirstCall/--Orexigen®Therapeutics,Inc...nthetreatmentofobesity,todayannouncedthatonNovembe...dofDirectorsgrantedaninducementstockoptiontopurcha...itsnewlyappointedHeadoftheGlobalContraveProgram. ,...ptiontotheextentpermittedbylawandhasanexercisepric...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--BioSpecificsTechnologiesC...opingfirstinclasscollagenase-basedproducts,todayan...esentattheupcomingPiperJaffray21stAnnualHealthCare...NewYorkPalaceHotelinNewYork,NY. ,, Alivewebcast...ts"intheInvestorRelationssectionoftheCompany,swebs...
Breaking Medicine Technology:MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Empire BlueCross BlueShield Launches Art Heals Program with Museum for African Art Greater New York Hospital Association 59161 1Empire BlueCross BlueShield Launches Art Heals Program with Museum for African Art Greater New York Hospital Association 59161 2Empire BlueCross BlueShield Launches Art Heals Program with Museum for African Art Greater New York Hospital Association 59161 3Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 1Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 2Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 3Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 4Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 5Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 1Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 2Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 3Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 4
...April 27 Pomegranate juice may slow the progres... according to new long-term research results being...of the American Urological Association (AUA). Rese...t for localized prostate cancer could benefit from...clinical trial followed a total of 48 participants...
...(R) System Capabilities Enable Powerful New TB Dia...heid (Nasdaq: CPHD ) today announced the release...r the European Directive on In Vitro Diagnostic ...icians will have access to a rapid test that can s... (MTB) and resistance to rifampicin (RIF), a comm...
Other Medicine Technology:Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption 2Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 2Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 3Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 4Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 5Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 6
...matched precision and reproducibility, so you can ... viral load values they can trust.,you detect si...ical decision points - without the variability see...hoose VERSANT HIV bDNA, consider this: it's the on...
...unodeficiency Virus (HIV-1) undergoes mutations in...ti-viral drug treatment. Some of the mutations hav...action of these drugs, diminishing the effectivene...n HIV-1 that correlate with drug resistance provid...
...assays provide superior specificity, thereby reduc...on. Vironostika HIV-1 Microelisa System is an enz...f antibody to HIV-1 in serum, plasma or dried bloo...System is an enzyme-linked immuosorbent assay for ...
OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
Medicine Products: